These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 24820257)
1. Hepatitis C virus-related knowledge and willingness to receive treatment among patients on methadone maintenance. Zeremski M; Dimova RB; Zavala R; Kritz S; Lin M; Smith BD; Zibbell JE; Talal AH J Addict Med; 2014; 8(4):249-57. PubMed ID: 24820257 [TBL] [Abstract][Full Text] [Related]
2. "Hepatitis C treatment turned me around:" Psychological and behavioral transformation related to hepatitis C treatment. Batchelder AW; Peyser D; Nahvi S; Arnsten JH; Litwin AH Drug Alcohol Depend; 2015 Aug; 153():66-71. PubMed ID: 26096534 [TBL] [Abstract][Full Text] [Related]
3. Hepatitis C infection, related services, and barriers to HCV treatment among drug users in methadone maintenance treatment (MMT) clinics in Shanghai, China. Li ZB; Zhang L; Wang J; Huang LP; Zhou ZR; Cao YN; Zhao M; Du J Harm Reduct J; 2017 Nov; 14(1):71. PubMed ID: 29096647 [TBL] [Abstract][Full Text] [Related]
4. Methadone maintenance patients' knowledge, attitudes, beliefs, and experiences concerning treatment for hepatitis C virus infection. Canfield KM; Smyth E; Batki SL Subst Use Misuse; 2010 Mar; 45(4):496-514. PubMed ID: 20141461 [TBL] [Abstract][Full Text] [Related]
5. Hepatitis C knowledge and alcohol consumption among patients receiving methadone maintenance treatment in Shanghai, China. Du J; Wang Z; Xie B; Zhao M Am J Drug Alcohol Abuse; 2012 May; 38(3):228-32. PubMed ID: 22242740 [TBL] [Abstract][Full Text] [Related]
6. Knowledge of hepatitis C and treatment willingness amongst people who inject drugs in an era of direct acting antivirals. Mah A; Hull MW; DeBeck K; Milloy MJ; Dobrer S; Nosova E; Wood E; Kerr T; Hayashi K Int J Drug Policy; 2017 Sep; 47():137-143. PubMed ID: 28347636 [TBL] [Abstract][Full Text] [Related]
7. Knowledge of and interest in hepatitis C treatment at a methadone clinic. Walley AY; White MC; Kushel MB; Song YS; Tulsky JP J Subst Abuse Treat; 2005 Mar; 28(2):181-7. PubMed ID: 15780548 [TBL] [Abstract][Full Text] [Related]
8. High prevalence but low awareness of hepatitis C virus infection among heroin users who received methadone maintenance therapy in Taiwan. Ng MH; Chou JY; Chang TJ; Lee PC; Shao WC; Lin TY; Chen VC; Gossop M Addict Behav; 2013 Apr; 38(4):2089-93. PubMed ID: 23403277 [TBL] [Abstract][Full Text] [Related]
9. Knowledge and barriers associated with assessment and treatment for hepatitis C virus infection among people who inject drugs. Treloar C; Hull P; Dore GJ; Grebely J Drug Alcohol Rev; 2012 Nov; 31(7):918-24. PubMed ID: 22612899 [TBL] [Abstract][Full Text] [Related]
10. Liver disease knowledge and acceptability of non-invasive liver fibrosis assessment among people who inject drugs in the drug and alcohol setting: The LiveRLife Study. Marshall AD; Micallef M; Erratt A; Telenta J; Treloar C; Everingham H; Jones SC; Bath N; How-Chow D; Byrne J; Harvey P; Dunlop A; Jauncey M; Read P; Collie T; Dore GJ; Grebely J Int J Drug Policy; 2015 Oct; 26(10):984-91. PubMed ID: 26256938 [TBL] [Abstract][Full Text] [Related]
11. Improvements in HCV-related Knowledge Among Substance Users on Opioid Agonist Therapy After an Educational Intervention. Zeremski M; Zavala R; Dimova RB; Chen Y; Kritz S; Sylvester C; Brown LS; Talal AH J Addict Med; 2016; 10(2):104-9. PubMed ID: 26881485 [TBL] [Abstract][Full Text] [Related]
12. Knowledge and attitudes about treatment for hepatitis C virus infection and barriers to treatment among current injection drug users in Australia. Doab A; Treloar C; Dore GJ Clin Infect Dis; 2005 Apr; 40 Suppl 5():S313-20. PubMed ID: 15768340 [TBL] [Abstract][Full Text] [Related]
13. Hepatitis C virus infection is independently associated with depression among methadone maintenance treatment heroin users in China. Wang Z; Du J; Zhao M; Page K; Xiao Z; Mandel JS Asia Pac Psychiatry; 2013 Sep; 5(3):191-6. PubMed ID: 23857926 [TBL] [Abstract][Full Text] [Related]
14. Hepatitis C among methadone maintenance treatment patients in Shanghai and Kunming, China. Hser Y; Du J; Li J; Zhao M; Chang YJ; Peng CY; Evans E J Public Health (Oxf); 2012 Mar; 34(1):24-31. PubMed ID: 22138488 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of a hepatitis C education intervention with clients enrolled in methadone maintenance and needle/syringe programs in Malaysia. Mukherjee TI; Pillai V; Ali SH; Altice FL; Kamarulzaman A; Wickersham JA Int J Drug Policy; 2017 Sep; 47():144-152. PubMed ID: 28652072 [TBL] [Abstract][Full Text] [Related]
16. The content and comprehensiveness of hepatitis C education in methadone maintenance and drug-free treatment units. Strauss SM; Astone JM; Hagan H; Des Jarlais DC J Urban Health; 2004 Mar; 81(1):38-47. PubMed ID: 15047782 [TBL] [Abstract][Full Text] [Related]
17. "Take Charge, Get Cured": Pilot testing a targeted mHealth treatment decision support tool for methadone patients with hepatitis C virus for acceptability and promise of efficacy. Jessop AB; Bass SB; Brajuha J; Alhajji M; Burke M; Gashat MT; Wellington C; Ventriglia N; Coleman J; D'Avanzo P J Subst Abuse Treat; 2020 Feb; 109():23-33. PubMed ID: 31856947 [TBL] [Abstract][Full Text] [Related]
18. Perceptions of Barriers and Benefits of HCV Treatment and Correlates to Treatment Intention in Methadone Patients. Jessop AB; Bass SB; Gutierrez M; Gashat MT J Health Care Poor Underserved; 2019; 30(4):1433-1454. PubMed ID: 31680107 [TBL] [Abstract][Full Text] [Related]
19. Trends and factors in human immunodeficiency virus and/or hepatitis C virus testing and infection among injection drug users newly entering methadone maintenance treatment in Guangdong Province, China 2006-2013: a consecutive cross sectional study. Liu Y; Liu Y; Zou X; Chen W; Ling L BMJ Open; 2017 Jul; 7(7):e015524. PubMed ID: 28710214 [TBL] [Abstract][Full Text] [Related]
20. Experience with viral hepatitis C treatment among people who inject drugs and participate in a methadone substitution treatment program. Krekulová L; Vavrinčíková L Epidemiol Mikrobiol Imunol; 2021; 70(1):18-25. PubMed ID: 33853334 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]